NASDAQ
MTEM

Molecular Templates Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Molecular Templates Inc Stock Price

Vitals

Today's Low:
$0.5600
Today's High:
$0.6700
Open Price:
$0.6600
52W Low:
$0.56
52W High:
$5.9
Prev. Close:
$0.6436
Volume:
119712

Company Statistics

Market Cap.:
$0.033 billion
Book Value:
0.462
Revenue TTM:
$0.033 billion
Operating Margin TTM:
-247.8%
Gross Profit TTM:
$-0.046 billion
Gross Profit TTM:
$-0.046 billion
Profit Margin:
-260.7%
Return on Assets TTM:
-26.7%
Return on Equity TTM:
-140.4%

Company Profile

Molecular Templates Inc had its IPO on 2005-02-04 under the ticker symbol MTEM.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Molecular Templates Inc has a staff strength of 0 employees.

Stock update

Shares of Molecular Templates Inc opened at $0.66 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.56 - $0.67, and closed at $0.59.

This is a -8.9% slip from the previous day's closing price.

A total volume of 119,712 shares were traded at the close of the day’s session.

In the last one week, shares of Molecular Templates Inc have slipped by -41.37%.

Molecular Templates Inc's Key Ratios

Molecular Templates Inc has a market cap of $0.033 billion, indicating a price to book ratio of 1.363 and a price to sales ratio of 0.994.

In the last 12-months Molecular Templates Inc’s revenue was $0.033 billion with a gross profit of $-0.046 billion and an EBITDA of $-0.075 billion. The EBITDA ratio measures Molecular Templates Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Molecular Templates Inc’s operating margin was -247.8% while its return on assets stood at -26.7% with a return of equity of -140.4%.

In Q2, Molecular Templates Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 70.8%.

Molecular Templates Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-1.384 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Molecular Templates Inc’s profitability.

Molecular Templates Inc stock is trading at a EV to sales ratio of 0.0087 and a EV to EBITDA ratio of 0.297. Its price to sales ratio in the trailing 12-months stood at 0.994.

Molecular Templates Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Molecular Templates Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Molecular Templates Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Molecular Templates Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Molecular Templates Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Molecular Templates Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.59
52-Week High
$5.9
52-Week Low
$0.56
Analyst Target Price
$8.33

Molecular Templates Inc stock is currently trading at $0.59 per share. It touched a 52-week high of $5.9 and a 52-week low of $5.9. Analysts tracking the stock have a 12-month average target price of $8.33.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Molecular Templates Inc

The stock symbol (also called stock or share ticker) of Molecular Templates Inc is MTEM

The IPO of Molecular Templates Inc took place on 2005-02-04

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$2.53
-0.24
-8.66%
$0.88
-0.02
-1.79%
$6
-0.08
-1.32%
Celyad SA (CYAD)
$1.05
-0
-0.02%
Xencor Inc (XNCR)
$27.43
-0.84
-2.97%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Molecular Templates, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of biological therapies for the treatment of cancer and other diseases. The company is headquartered in Austin, Texas.

Address

9301 AMBERGLEN BLVD, SUITE 100, AUSTIN, TX, US